Growth Metrics

Conmed (CNMD) Profit After Tax Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -12.28%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 99.26%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 4.70%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 125.69%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -27.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 51.30%
10 Conmed 1.06 Bn 1.02 Bn 183.45 Mn 129.09%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 129.09%
Dec 31, 2025 -50.41%
Sep 30, 2025 -94.16%
Jun 30, 2025 -28.54%
Mar 31, 2025 -69.37%
Dec 31, 2024 2.07%
Sep 30, 2024 209.30%
Jun 30, 2024 118.29%
Mar 31, 2024 983.51%
Dec 31, 2023 24.40%
Sep 30, 2023 -65.68%
Jun 30, 2023 108.16%
Mar 31, 2023 -87.85%
Dec 31, 2022 8.75%
Sep 30, 2022 208.74%
Jun 30, 2022 -1,366.30%
Mar 31, 2022 51.88%
Dec 31, 2021 1.26%
Sep 30, 2021 118.22%
Jun 30, 2021 148.50%
Mar 31, 2021 66.36%
Dec 31, 2020 61.66%
Sep 30, 2020 -1.72%
Jun 30, 2020 -581.12%
Mar 31, 2020 480.51%
Dec 31, 2019 -4.60%
Sep 30, 2019 19.66%
Jun 30, 2019 -34.68%
Mar 31, 2019 -90.42%
Dec 31, 2018 -66.48%
Sep 30, 2018 -19.06%
Jun 30, 2018 42.03%
Mar 31, 2018 334.48%
Dec 31, 2017 596.12%
Sep 30, 2017 -1.91%
Jun 30, 2017 112.86%
Mar 31, 2017 -100.66%
Dec 31, 2016 -14.57%
Sep 30, 2016 -17.31%
Jun 30, 2016 -61.35%
Mar 31, 2016 -135.88%
Dec 31, 2015 -30.75%
Sep 30, 2015 349.95%
Jun 30, 2015 -27.25%
Mar 31, 2015 -26.83%
Dec 31, 2014 10.87%
Sep 30, 2014 -65.32%
Jun 30, 2014 7.57%
Mar 31, 2014 -17.78%
Dec 31, 2013 -6.15%
Sep 30, 2013 -38.98%
Jun 30, 2013 -7.41%
Mar 31, 2013 5.26%
Dec 31, 2012 143.36%
Sep 30, 2012 13.51%
Jun 30, 2012 18.62%
Mar 31, 2012 10.82%
Dec 31, 2011 -460.97%
Sep 30, 2011 -6.25%
Jun 30, 2011 18.81%